John Yung
Stock Analyst at Citi
(2.14)
# 3,192
Out of 5,073 analysts
26
Total ratings
34.6%
Success rate
1.5%
Average return
Main Sectors:
Stocks Rated by John Yung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1093 CSPC Pharmaceutical Group Limited | Reiterated: Buy | $11.50 → $14.00 | $8.28 | +69.18% | 5 | Aug 21, 2026 | |
| HKG: 2196 Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | Reiterated: Buy | $35.30 | $16.27 | +116.96% | 2 | Oct 29, 2025 | |
| HKG: 2005 SSY Group Limited | Reiterated: Buy | $7.00 → $5.00 | $2.58 | n/a | 2 | Sep 5, 2025 | |
| HKG: 2273 Gushengtang Holdings Limited | Reiterated: Buy | $55.00 | $26.68 | n/a | 3 | Sep 1, 2025 | |
| HKG: 1513 Livzon Pharmaceutical Group Inc. | Reiterated: Buy | $48.00 | $20.30 | n/a | 1 | Aug 26, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Reiterated: Buy | $35.00 → $40.00 | $44.52 | n/a | 2 | Aug 21, 2025 | |
| HKG: 2268 WuXi XDC Cayman Inc. | Reiterated: Buy | $41.00 → $70.00 | $69.80 | n/a | 2 | Aug 20, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Reiterated: Buy | $32.00 → $45.00 | $32.06 | n/a | 2 | Aug 20, 2025 | |
| HKG: 1177 Sino Biopharmaceutical Limited | Reiterated: Buy | $8.80 → $10.80 | $4.93 | n/a | 2 | Aug 19, 2025 | |
| HKG: 0241 Alibaba Health Information Technology Limited | Reiterated: Buy | $8.50 | $2.85 | n/a | 1 | Jul 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74.00 | $182.90 | n/a | 1 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40.00 → $38.90 | $22.20 | n/a | 2 | Aug 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62.00 | $81.35 | n/a | 1 | Nov 10, 2023 |
CSPC Pharmaceutical Group Limited
Aug 21, 2026
Reiterated: Buy
Price Target: $11.50 → $14.00
Current: $8.28
Upside: +69.18%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Oct 29, 2025
Reiterated: Buy
Price Target: $35.30
Current: $16.27
Upside: +116.96%
SSY Group Limited
Sep 5, 2025
Reiterated: Buy
Price Target: $7.00 → $5.00
Current: $2.58
Upside: n/a
Gushengtang Holdings Limited
Sep 1, 2025
Reiterated: Buy
Price Target: $55.00
Current: $26.68
Upside: n/a
Livzon Pharmaceutical Group Inc.
Aug 26, 2025
Reiterated: Buy
Price Target: $48.00
Current: $20.30
Upside: n/a
WuXi Biologics (Cayman) Inc.
Aug 21, 2025
Reiterated: Buy
Price Target: $35.00 → $40.00
Current: $44.52
Upside: n/a
WuXi XDC Cayman Inc.
Aug 20, 2025
Reiterated: Buy
Price Target: $41.00 → $70.00
Current: $69.80
Upside: n/a
Hansoh Pharmaceutical Group Company Limited
Aug 20, 2025
Reiterated: Buy
Price Target: $32.00 → $45.00
Current: $32.06
Upside: n/a
Sino Biopharmaceutical Limited
Aug 19, 2025
Reiterated: Buy
Price Target: $8.80 → $10.80
Current: $4.93
Upside: n/a
Alibaba Health Information Technology Limited
Jul 4, 2025
Reiterated: Buy
Price Target: $8.50
Current: $2.85
Upside: n/a
Dec 27, 2024
Reiterated: Buy
Price Target: $74.00
Current: $182.90
Upside: n/a
Aug 30, 2024
Reiterated: Buy
Price Target: $40.00 → $38.90
Current: $22.20
Upside: n/a
Nov 10, 2023
Reiterated: Buy
Price Target: $62.00
Current: $81.35
Upside: n/a